Achieved additional $75 million in partnering proceeds from Sanofi and GileadGranted license to additional preclinical program to Gilead that ...

Sanofi remporte cette année la palme du champion climatique du CAC40, selon une analyse réalisée par Les Ateliers du futur.

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP -- Raised ...

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited announced the ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2025. "This quarter highlights ...

Generative AI models aren’t perfect. Despite constant improvement, they still hallucinate and make mistakes. And for a ...

Global drug stocks rally as the FDA names Richard Pazdur, its top cancer drug regulator, as the head of its influential ...

The antibody-mediated rejection (AMR) market is set for solid expansion through 2034, driven by rising transplant volumes, ...

CDC will hold its next meeting in December, with its agenda including a vote on whether to recommend changes to the current ...

A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...